Cancer immunotherapy drugs only work for a minority of patients, but a generic drug now used to increase blood flow may be able to improve those odds, a study by Columbia University Medical Center researchers suggests.
Al final de los 1800, un cirujano…
At a special event at Columbia, oncologists and scientists will discuss how new research is changing the way cancer is being treated.
At Columbia, every pediatric cancer patient’s tumor is sequenced, so personalized treatment may be considered.
Advances in how the immune system can be harnessed to fight cancer offer new hope to patients with lung cancer.
Director of the National Cancer Institute, Harold Varmus, MD'66, talked about the challenges and goals of precision medicine's efforts to tackle cancer.